Skip to main navigation Skip to search Skip to main content

National Institute of Allergy and Infectious Diseases (NIAID) Researchers Provide Details of New Studies and Findings in the Area of Ebola Virus (Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase ...)

Press/Media

Period17 Apr 2024

Media coverage

1

Media coverage

  • TitleNational Institute of Allergy and Infectious Diseases (NIAID) Researchers Provide Details of New Studies and Findings in the Area of Ebola Virus (Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase ...)
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date17/04/24
    PersonsMerlin Robb